TH1601006980A - - Google Patents

Info

Publication number
TH1601006980A
TH1601006980A TH1601006980A TH1601006980A TH1601006980A TH 1601006980 A TH1601006980 A TH 1601006980A TH 1601006980 A TH1601006980 A TH 1601006980A TH 1601006980 A TH1601006980 A TH 1601006980A TH 1601006980 A TH1601006980 A TH 1601006980A
Authority
TH
Thailand
Prior art keywords
page
disclaimers
palmitic
antagonists
amendment
Prior art date
Application number
TH1601006980A
Other languages
English (en)
Thai (th)
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ filed Critical นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์
Publication of TH1601006980A publication Critical patent/TH1601006980A/th

Links

TH1601006980A 2015-05-22 TH1601006980A (https=)

Publications (1)

Publication Number Publication Date
TH1601006980A true TH1601006980A (https=) 2019-11-18

Family

ID=

Similar Documents

Publication Publication Date Title
HUE054690T2 (hu) 8-Oxetán-3-il-3,8-diazabiciklo[3.2.1]oktán-3-il-csoporttal szubsztituált vegyületek HIV inhibitorokként
EP3493799A4 (en) CANNABIS
IL250239A0 (en) Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
HRP20220075T1 (hr) Tekuća formulacija koja sadrži nikotin za aerosolnu primjenu
EP3493798A4 (en) CANNABIS
LT3310904T (lt) Ląstelinė kryptinga sistema aktyvių ingredientų tiekimui
DK3518892T5 (da) Farmaceutisk formulering, der indeholder en insulinforbindelse
IL257371A (en) Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient
MA43705A (fr) Formulation pharmaceutique
HUE052833T2 (hu) Eljárás 2,5-furándikarbonsav (FDCA) elõállítására
HUE049437T2 (hu) Hatóanyagként heterociklusos diamino-karboxamid vegyületet tartalmazó gyógyászati készítmény
CL2016001763A1 (es) Antagonistas selectivos de nr2b
EA201791716A1 (ru) Фармацевтический состав
EP3402470A4 (en) STABLE PHARMACEUTICAL COMPOSITION
JO3456B1 (ar) فيروتيوكسيتين بيروجلوتامات
MA47516A (fr) Composition pharmaceutique
EA201691741A1 (ru) Фармацевтическая композиция
EP3383371A4 (en) PHARMACEUTICAL FORMULATION
EP3646866A4 (en) PHARMACEUTICAL PREPARATION
CY1123408T1 (el) Φαρμακευτικες συνθεσεις και χρηση των αυτων
MY182634A (en) Pharmaceutical containing sodium-dependent phosphate transporter inhibitor
EP3646867A4 (en) PHARMACEUTICAL COMPOSITION
EP3646863A4 (en) PHARMACEUTICAL COMPOSITION
EP3524250A4 (en) PHARMACEUTICAL COMPOSITION
EP3881841A4 (en) PHARMACEUTICAL COMPOSITION